T cell receptor beta variable 30 (TRBV30)

T cell receptor beta variable 30 encodes the variable region of the beta chain of alpha-beta T cell receptors, which are present on T lymphocytes and are required for antigen-specific immune responses. TRBV30 interacts with peptide-major histocompatibility complexes on antigen-presenting cells, leading to T cell activation, intracellular signaling cascades, and adaptive immunity. It is part of the T cell receptor beta locus on chromosome 7q34, and its diversity is generated via V(D)J recombination in the thymus[1][3][6][7]. No evidence of direct clinical application, drug targeting, or routine biomarker use for TRBV30 alone was found; its relevance is principally as a fundamental immunological receptor component.

Other names

TRBV30TCRBV20S1A1N2TCRBV30S1V_segment translation productTVB30

Drugs that target the T cell receptor would generally act by modulating T cell activation—e.g., anti-CD3 antibodies inhibit or activate the TCR complex. However, no approved drugs target the variable region TRBV30 specifically[1][3].